Answers are grounded in this paper and cite their sources.
OBJECTIVES: This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the comparative effectiveness of monoclonal antibodies (mAbs) for preventing respiratory syncytial virus (RSV) infection in children, and to evaluate the relative rankings for benefits and harms of mAbs for preventing RSV in children.
No takes yet. Share an insight, caveat, or question.
Garegnani et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: